Czy psychodeliki staną się lekami?
Kosmos August 8, 2024 DOI: 10.36921/kos.2024_2999 via OpenAlex
Summary
AI-generated from the abstractInterest in using psychedelics to treat depression and addiction has grown over the past decade, sparking new research. This work recounts the history of psychedelic experiments in the 1950s and 1960s, their international prohibition in the 1970s, and the revival of medical research in the 21st century. It discusses possible mechanisms behind their therapeutic effects, associated risks, and changing legal status in some countries. The text predicts the emergence of a new medical field based on classic psychedelics and their novel analogs.
Study at a glance
| Characteristics | Historical analysis Peer reviewed |
|---|---|
| Keywords | Computer science |
| Key finding | A new branch of medicine based on classic psychedelics and their analogs is predicted to develop. |
Abstract
In the past decade, there has been a surge of interest in the therapeutic use of psychedelics, especially in the treatment of depression and addiction, resulting in many new research projects on their properties. This publication outlines the history of scientific experiments conducted with psychedelics in the 1950s and 1960s, as well as their subsequent international outlawing in the 1970s and the resurgence of research into their medical potential with the onset of the 21st century. Additionally, it discusses the potential mechanisms responsible for their therapeutic impact, the dangers accompanying their use, and changes in their legal status in some countries. The text also makes predictions about the development of a new branch of medicine based on the use of classic psychedelics and their new analogs.